Midpregnancy prediction of pre-eclampsia using serum biomarkers sFlt-1 and PlGF

Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health - Tập 16 - Trang 112-119 - 2019
Carin Black1,2, Ahmed Al-Amin3,4, Caroline Stolarek1, Stefan C. Kane1,2,3, Daniel Lorber Rolnik5,6, Adrienne White1, Fabricio da Silva Costa7,5, Shaun Brennecke1,2
1Pregnancy Research Centre, Department of Maternal-Fetal Medicine, Royal Women’s Hospital, Parkville, Victoria, Australia
2The University of Melbourne, Department of Obstetrics and Gynaecology, The Royal Women’s Hospital, Parkville, Victoria, Australia
3Pauline Gandel Imaging Centre, Royal Women’s Hospital, Parkville, Victoria, Australia
4Monash Ultrasound for Women, Clayton, Victoria, Australia
5Department of Obstetrics and Gynaecology, Monash University, Clayton, Victoria, Australia
6Perinatal Services, Monash Medical Centre, Clayton, Victoria, Australia
7Department of Gynecology and Obstetrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil

Tài liệu tham khảo

Vlachadis, 2014, The incidence of preeclampsia and eclampsia in Australia: 2000 through 2008, Am. J. Obstet. Gynecol, 210, 173, 10.1016/j.ajog.2013.08.034

Khan, 2006, WHO analysis of causes of maternal death: a systematic review, Lancet, 367, 1066, 10.1016/S0140-6736(06)68397-9

Redman, 2015, Preeclampsia, biomarkers, syncytiotrophoblast stress, and placental capacity, Am. J. Obstet. Gynecol., 213

Levine, 2004, Circulating angiogenic factors and the risk of preeclampsia, NEJM, 350, 672, 10.1056/NEJMoa031884

Tidwell, 2001, Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia, Am. J. Obstet. Gynecol., 184, 1267, 10.1067/mob.2001.113129

Polliotti, 2003, Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia, Obstet. Gynecol., 101, 1266

Taylor, 2003, Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies, Am. J. Obstet. Gynecol., 188, 177, 10.1067/mob.2003.111

Staff, 2005, Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia, Eur. J. Obstet. Gynecol. Reprod. Biol., 122, 33, 10.1016/j.ejogrb.2004.11.015

Kim, 2007, Increased sFlt-1 to PlGF ratio in women who subsequently develop preeclampsia, J. Korean. Med. Sci., 22, 873, 10.3346/jkms.2007.22.5.873

Moore Simas, 2007, Angiogenic factors for the prediction of preeclampsia in high-risk women, Am. J. Obstet. Gynecol., 197, 10.1016/j.ajog.2007.06.030

Rana, 2007, Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia, Hypertension, 50, 137, 10.1161/HYPERTENSIONAHA.107.087700

Lim, 2008, Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors, Obstet. Gynecol., 111, 1403, 10.1097/AOG.0b013e3181719b7a

Shokry, 2010, Maternal serum placental growth factor and soluble fms-like tyrosine kinase 1 as early predictors of preeclampsia, Acta. Obstet. Gynecol. Scand., 89, 143, 10.3109/00016340903289892

Rohra, 2012, Prediction of pre-eclampsia during early pregnancy in primiparas with soluble fms-like tyrosine kinase-1 and placental growth factor, Natl. Med. J. India, 25, 68

Hassan, 2013, An elevated maternal plasma soluble fms-like tyrosine kinase-1 to placental growth factor ratio at midtrimester is a useful predictor for preeclampsia, Obstet. Gynecol. Int., 202346

Perales, 2016, sFlt-1/PlGF for early-onset pre-eclampsia prediction: STEPS (Study of Early Pre-eclampsia in Spain), Ultrasound Obstet. Gynecol., 50, 373, 10.1002/uog.17373

Roberge, 2012, Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis, Fetal. Diagn. Ther., 31, 141, 10.1159/000336662

Rolnik, 2017, Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia, NEJM, 377, 613, 10.1056/NEJMoa1704559

Australia’s mothers and babies 2016 - in brief. Perinatal statistics series no. 34. Cat. no. PER Australian Institute of Health and Welfare 2018 AIHW Canberra 97.

Chappell, 2013, Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study, Circulation, 128, 2121, 10.1161/CIRCULATIONAHA.113.003215

Zeisler, 2016, Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia, NEJM, 374, 13, 10.1056/NEJMoa1414838

McCarthy, 2018, Performance of commercially available placental growth factor tests in women with suspected preterm pre-eclampsia; the COMPARE study, Ultrasound Obstet. Gynecol.

Meads, 2008, Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling, Health. Technol. Assess., 12, 10.3310/hta12060

Henderson, 2017

Brown, 2018, The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice, Pregnancy Hypertens., 72, 24, 10.1161/HYPERTENSIONAHA.117.10803

Harris, 2009, Research electronic data capture (REDCap) - a metadata-driven methodology and workflow process for providing translational research informatics support, J. Biomed. Inform., 42, 377, 10.1016/j.jbi.2008.08.010

Brown, 2001, The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP), Hypertens. Pregnancy, 20, ix, 10.3109/10641950109152635

Tranquilli, 2014, The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP, Pregnancy Hypertens., 4, 97, 10.1016/j.preghy.2014.02.001

Figueras, 2014, Update on the diagnosis and classification of fetal growth restriction and proposal of a stage-based management protocol, Fetal. Diagn. Ther., 36, 86, 10.1159/000357592

Su, 2001, Decreased maternal serum placenta growth factor in early second trimester and preeclampsia, Obstet. Gynecol., 97, 898

Tjoa, 2001, Plasma placenta growth factor levels in midtrimester pregnancies, Obstet. Gynecol., 98, 600

Unal, 2007, Second-trimester angiogenic factors as biomarkers for future-onset preeclampsia, Am. J. Obstet. Gynecol., 197, 10.1016/j.ajog.2007.05.022

Ghosh, 2012, Serum PLGF as a potential biomarker for predicting the onset of preeclampsia, Arch. Gynecol. Obstet., 285, 417, 10.1007/s00404-011-1960-4

Lambert-Messerlian, 2014, Use of first or second trimester serum markers, or both, to predict preeclampsia, Pregnancy Hypertens., 4, 271, 10.1016/j.preghy.2014.07.001

Shim, 2015, Midtrimester maternal plasma concentrations of angiopoietin 1, angiopoietin 2, and placental growth factor in pregnant women who subsequently develop preeclampsia, Obstet. Gynecol. Sci., 58, 10, 10.5468/ogs.2015.58.1.10

Ghosh, 2013, Is serum placental growth factor more effective as a biomarker in predicting early onset preeclampsia in early second trimester than in first trimester of pregnancy?, Arch. Gynecol. Obstet., 287, 865, 10.1007/s00404-012-2662-2

Kleinrouweler, 2012, Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis, BJOG, 119, 778, 10.1111/j.1471-0528.2012.03311.x

McElrath, 2012, Longitudinal evaluation of predictive value for preeclampsia of circulating angiogenic factors through pregnancy, Am. J. Obstet. Gynecol., 207, 10.1016/j.ajog.2012.08.010

Myatt, 2013, Can changes in angiogenic biomarkers between the first and second trimesters of pregnancy predict development of pre-eclampsia in a low-risk nulliparous patient population?, BJOG, 120, 1183, 10.1111/1471-0528.12128

Myers, 2013, Angiogenic factors combined with clinical risk factors to predict preterm pre-eclampsia in nulliparous women: a predictive test accuracy study, BJOG, 120, 1215, 10.1111/1471-0528.12195

Litwinska, 2018, Management of pregnancies after combined screening for pre-eclampsia at 19-24 weeks' gestation, Ultrasound Obstet. Gynecol., 52, 365, 10.1002/uog.19099

Roberts, 2001, Preeclampsia: is there value in assessing before clinically evident disease?, Obstet. Gynecol., 98, 596, 10.1097/00006250-200110000-00013

Lam, 2005, Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia, Hypertension, 46, 1077, 10.1161/01.HYP.0000187899.34379.b0

Grill, 2009, Potential markers of preeclampsia - a review, Reprod. Biol. Endocrinol., 7, 70, 10.1186/1477-7827-7-70

Wang, 2009, Preeclampsia: the role of angiogenic factors in its pathogenesis, Physiology, 24, 147, 10.1152/physiol.00043.2008

Lapaire, 2010, The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor: current knowledge, clinical implications and future application, Eur. J. Obstet. Gynecol. Reprod. Biol., 151, 122, 10.1016/j.ejogrb.2010.04.009

Steegers, 2010, Pre-eclampsia, Lancet, 376, 631, 10.1016/S0140-6736(10)60279-6

Maynard, 2011, Angiogenic factors and preeclampsia, Semin. Nephrol., 31, 33, 10.1016/j.semnephrol.2010.10.004

Askie, 2007, Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data, Lancet, 369, 1791, 10.1016/S0140-6736(07)60712-0

Duley, 2007, Antiplatelet agents for preventing pre-eclampsia and its complications, Cochrane Database Syst. Rev., 2, CD004659

Bujold, 2010, Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis, Obstet. Gynecol., 116, 402, 10.1097/AOG.0b013e3181e9322a

Roberge, 2013, Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis, Ultrasound Obstet. Gynecol., 41, 491, 10.1002/uog.12421

Hofmeyr, 2014, Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems, Cochrane Database Syst. Rev., 6

Roberge, 2017, The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis, Am. J. Obstet. Gynecol., 216, 10.1016/j.ajog.2016.09.076

Roberge, 2018, Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis, Am. J. Obstet. Gyncecol., 218

Thông tin
Thông tin xuất bản

Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health

Tập 16

112-119

Thông tin tác giả